ŞAHİN, E. Et Al. 2019. Vulpinic acid, a lichen metabolite, emerges as a potential drug candidate in the therapy of oxidative stress-related diseases, such as atherosclerosis. HUMAN & EXPERIMENTAL TOXICOLOGY , vol.38, no.6 , 675-684.

ŞAHİN, E., Psav, S. D., Avan, I., Candan, M., ŞAHİNTÜRK, V., & Koparal, A. T., (2019). Vulpinic acid, a lichen metabolite, emerges as a potential drug candidate in the therapy of oxidative stress-related diseases, such as atherosclerosis. HUMAN & EXPERIMENTAL TOXICOLOGY , vol.38, no.6, 675-684.

ŞAHİN, ERHAN Et Al. "Vulpinic acid, a lichen metabolite, emerges as a potential drug candidate in the therapy of oxidative stress-related diseases, such as atherosclerosis," HUMAN & EXPERIMENTAL TOXICOLOGY , vol.38, no.6, 675-684, 2019

ŞAHİN, ERHAN Et Al. "Vulpinic acid, a lichen metabolite, emerges as a potential drug candidate in the therapy of oxidative stress-related diseases, such as atherosclerosis." HUMAN & EXPERIMENTAL TOXICOLOGY , vol.38, no.6, pp.675-684, 2019

ŞAHİN, E. Et Al. (2019) . "Vulpinic acid, a lichen metabolite, emerges as a potential drug candidate in the therapy of oxidative stress-related diseases, such as atherosclerosis." HUMAN & EXPERIMENTAL TOXICOLOGY , vol.38, no.6, pp.675-684.

@article{article, author={ERHAN ŞAHİN Et Al. }, title={Vulpinic acid, a lichen metabolite, emerges as a potential drug candidate in the therapy of oxidative stress-related diseases, such as atherosclerosis}, journal={HUMAN & EXPERIMENTAL TOXICOLOGY}, year=2019, pages={675-684} }